nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—CYP19A1—Paclitaxel—lung cancer	0.305	1	CbGbCtD
Carbimazole—TPO—Differentiation Pathway—ALK—lung cancer	0.0159	0.0816	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—CSF3—lung cancer	0.0109	0.0558	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—NODAL—lung cancer	0.00971	0.0498	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—AZIN2—lung cancer	0.00667	0.0342	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—TF—lung cancer	0.00626	0.0321	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—RHEB—lung cancer	0.00495	0.0254	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—HSD17B10—lung cancer	0.00462	0.0237	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—HSD17B10—lung cancer	0.00434	0.0223	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—CKB—lung cancer	0.0043	0.0221	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—AREG—lung cancer	0.00418	0.0214	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—CNDP2—lung cancer	0.00404	0.0207	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—KIT—lung cancer	0.00303	0.0155	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—EGF—lung cancer	0.00299	0.0154	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IL6R—lung cancer	0.00281	0.0144	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.00278	0.0143	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.00274	0.0141	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.00225	0.0116	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—GCLC—lung cancer	0.00212	0.0109	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—VEGFA—lung cancer	0.00181	0.00929	CbGpPWpGaD
Carbimazole—TPO—Amino acid and derivative metabolism—NQO1—lung cancer	0.00178	0.00916	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP2E1—lung cancer	0.0017	0.00871	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.00161	0.00828	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.00159	0.00817	CbGpPWpGaD
Carbimazole—CYP19A1—Endogenous sterols—POMC—lung cancer	0.00158	0.00812	CbGpPWpGaD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—IL6—lung cancer	0.00145	0.00743	CbGpPWpGaD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.00137	0.00704	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CAT—lung cancer	0.00136	0.00699	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.00135	0.00695	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTM2—lung cancer	0.00132	0.00679	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CNDP2—lung cancer	0.00132	0.00679	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.00131	0.00671	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTM2—lung cancer	0.0013	0.00669	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IL6—lung cancer	0.00125	0.00643	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—RHEB—lung cancer	0.00125	0.0064	CbGpPWpGaD
Carbimazole—TPO—Metabolism—COL4A3BP—lung cancer	0.00122	0.00628	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AZIN2—lung cancer	0.00122	0.00628	CbGpPWpGaD
Carbimazole—CYP19A1—Tryptophan metabolism—CYP1A1—lung cancer	0.00122	0.00625	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—CYP2A7—lung cancer	0.0012	0.00614	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—lung cancer	0.00119	0.00608	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP2A7—lung cancer	0.00118	0.00605	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—RAF1—lung cancer	0.00115	0.00589	CbGpPWpGaD
Carbimazole—Angioedema—Vinorelbine—lung cancer	0.00113	0.00225	CcSEcCtD
Carbimazole—Pruritus—Teniposide—lung cancer	0.00112	0.00224	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—MTOR—lung cancer	0.00112	0.00575	CbGpPWpGaD
Carbimazole—Neutropenia—Paclitaxel—lung cancer	0.00111	0.00222	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.00111	0.00571	CbGpPWpGaD
Carbimazole—Malaise—Vinorelbine—lung cancer	0.00111	0.00222	CcSEcCtD
Carbimazole—Leukopenia—Vinorelbine—lung cancer	0.0011	0.0022	CcSEcCtD
Carbimazole—Aplastic anaemia—Methotrexate—lung cancer	0.00109	0.00217	CcSEcCtD
Carbimazole—Liver function test abnormal—Docetaxel—lung cancer	0.00108	0.00215	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Topotecan—lung cancer	0.00107	0.00214	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTA3—lung cancer	0.00107	0.00547	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Erlotinib—lung cancer	0.00106	0.00212	CcSEcCtD
Carbimazole—Angiopathy—Irinotecan—lung cancer	0.00106	0.00212	CcSEcCtD
Carbimazole—Jaundice—Etoposide—lung cancer	0.00105	0.00211	CcSEcCtD
Carbimazole—Stomatitis—Etoposide—lung cancer	0.00105	0.00211	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MSH6—lung cancer	0.00105	0.00541	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTA3—lung cancer	0.00105	0.00539	CbGpPWpGaD
Carbimazole—Myalgia—Vinorelbine—lung cancer	0.00105	0.0021	CcSEcCtD
Carbimazole—Arthralgia—Vinorelbine—lung cancer	0.00105	0.0021	CcSEcCtD
Carbimazole—Mouth ulceration—Methotrexate—lung cancer	0.00105	0.00209	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Vinorelbine—lung cancer	0.00104	0.00208	CcSEcCtD
Carbimazole—TPO—Metabolism—ATP5H—lung cancer	0.00104	0.00534	CbGpPWpGaD
Carbimazole—Discomfort—Vinorelbine—lung cancer	0.00104	0.00207	CcSEcCtD
Carbimazole—Stomatitis—Paclitaxel—lung cancer	0.00103	0.00207	CcSEcCtD
Carbimazole—Angiopathy—Gemcitabine—lung cancer	0.00103	0.00206	CcSEcCtD
Carbimazole—Alopecia—Irinotecan—lung cancer	0.00103	0.00206	CcSEcCtD
Carbimazole—Agranulocytosis—Etoposide—lung cancer	0.00101	0.00202	CcSEcCtD
Carbimazole—Alopecia—Gemcitabine—lung cancer	0.001	0.00201	CcSEcCtD
Carbimazole—Hepatocellular injury—Doxorubicin—lung cancer	0.001	0.002	CcSEcCtD
Carbimazole—Rash—Teniposide—lung cancer	0.001	0.002	CcSEcCtD
Carbimazole—Dermatitis—Teniposide—lung cancer	0.000999	0.002	CcSEcCtD
Carbimazole—Infection—Vinorelbine—lung cancer	0.000999	0.002	CcSEcCtD
Carbimazole—Feeling abnormal—Vinblastine—lung cancer	0.000997	0.00199	CcSEcCtD
Carbimazole—Headache—Teniposide—lung cancer	0.000994	0.00199	CcSEcCtD
Carbimazole—Nervous system disorder—Vinorelbine—lung cancer	0.000986	0.00197	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000985	0.00506	CbGpPWpGaD
Carbimazole—Thrombocytopenia—Vinorelbine—lung cancer	0.000985	0.00197	CcSEcCtD
Carbimazole—Skin disorder—Vinorelbine—lung cancer	0.000977	0.00195	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTA4—lung cancer	0.000975	0.005	CbGpPWpGaD
Carbimazole—CYP19A1—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000972	0.00499	CbGpPWpGaD
Carbimazole—Feeling abnormal—Topotecan—lung cancer	0.000969	0.00194	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTA4—lung cancer	0.000961	0.00493	CbGpPWpGaD
Carbimazole—Pancytopenia—Docetaxel—lung cancer	0.000957	0.00191	CcSEcCtD
Carbimazole—Haemoglobin—Paclitaxel—lung cancer	0.000957	0.00191	CcSEcCtD
Carbimazole—Haemorrhage—Paclitaxel—lung cancer	0.000952	0.0019	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTA2—lung cancer	0.00095	0.00487	CbGpPWpGaD
Carbimazole—Ill-defined disorder—Irinotecan—lung cancer	0.000943	0.00188	CcSEcCtD
Carbimazole—Neutropenia—Docetaxel—lung cancer	0.000943	0.00188	CcSEcCtD
Carbimazole—Nausea—Teniposide—lung cancer	0.000942	0.00188	CcSEcCtD
Carbimazole—Aplastic anaemia—Doxorubicin—lung cancer	0.000942	0.00188	CcSEcCtD
Carbimazole—Alopecia—Cisplatin—lung cancer	0.000937	0.00187	CcSEcCtD
Carbimazole—Urticaria—Topotecan—lung cancer	0.000934	0.00187	CcSEcCtD
Carbimazole—Body temperature increased—Topotecan—lung cancer	0.000929	0.00186	CcSEcCtD
Carbimazole—TPO—Metabolism—PLBD1—lung cancer	0.000928	0.00476	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AHR—lung cancer	0.00092	0.00472	CbGpPWpGaD
Carbimazole—Body temperature increased—Erlotinib—lung cancer	0.000919	0.00184	CcSEcCtD
Carbimazole—Ill-defined disorder—Gemcitabine—lung cancer	0.000918	0.00184	CcSEcCtD
Carbimazole—Malaise—Irinotecan—lung cancer	0.000916	0.00183	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTA1—lung cancer	0.000916	0.0047	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000916	0.00183	CcSEcCtD
Carbimazole—Leukopenia—Irinotecan—lung cancer	0.00091	0.00182	CcSEcCtD
Carbimazole—Mouth ulceration—Doxorubicin—lung cancer	0.000907	0.00181	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—SRC—lung cancer	0.000898	0.00461	CbGpPWpGaD
Carbimazole—Malaise—Gemcitabine—lung cancer	0.000893	0.00178	CcSEcCtD
Carbimazole—Hypersensitivity—Vinblastine—lung cancer	0.000892	0.00178	CcSEcCtD
Carbimazole—Leukopenia—Gemcitabine—lung cancer	0.000886	0.00177	CcSEcCtD
Carbimazole—Angiopathy—Etoposide—lung cancer	0.000881	0.00176	CcSEcCtD
Carbimazole—Jaundice—Docetaxel—lung cancer	0.000876	0.00175	CcSEcCtD
Carbimazole—Stomatitis—Docetaxel—lung cancer	0.000876	0.00175	CcSEcCtD
Carbimazole—Hypersensitivity—Topotecan—lung cancer	0.000866	0.00173	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—AKR1C1—lung cancer	0.000866	0.00444	CbGpPWpGaD
Carbimazole—Angiopathy—Paclitaxel—lung cancer	0.000864	0.00173	CcSEcCtD
Carbimazole—Alopecia—Etoposide—lung cancer	0.000858	0.00171	CcSEcCtD
Carbimazole—Ill-defined disorder—Cisplatin—lung cancer	0.000856	0.00171	CcSEcCtD
Carbimazole—Discomfort—Irinotecan—lung cancer	0.000855	0.00171	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—UGT1A1—lung cancer	0.000852	0.00437	CbGpPWpGaD
Carbimazole—TPO—Metabolism—HSD17B10—lung cancer	0.000849	0.00436	CbGpPWpGaD
Carbimazole—Myalgia—Gemcitabine—lung cancer	0.000843	0.00168	CcSEcCtD
Carbimazole—Arthralgia—Gemcitabine—lung cancer	0.000843	0.00168	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—NCOA3—lung cancer	0.000843	0.00433	CbGpPWpGaD
Carbimazole—Alopecia—Paclitaxel—lung cancer	0.000841	0.00168	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—UGT1A1—lung cancer	0.00084	0.00431	CbGpPWpGaD
Carbimazole—Agranulocytosis—Docetaxel—lung cancer	0.000839	0.00168	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000838	0.0043	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000837	0.00167	CcSEcCtD
Carbimazole—Discomfort—Gemcitabine—lung cancer	0.000833	0.00166	CcSEcCtD
Carbimazole—Malaise—Cisplatin—lung cancer	0.000832	0.00166	CcSEcCtD
Carbimazole—Pruritus—Topotecan—lung cancer	0.000832	0.00166	CcSEcCtD
Carbimazole—Feeling abnormal—Vinorelbine—lung cancer	0.000829	0.00166	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—MAPK3—lung cancer	0.000827	0.00424	CbGpPWpGaD
Carbimazole—Leukopenia—Cisplatin—lung cancer	0.000826	0.00165	CcSEcCtD
Carbimazole—Infection—Irinotecan—lung cancer	0.000824	0.00165	CcSEcCtD
Carbimazole—Pruritus—Erlotinib—lung cancer	0.000823	0.00164	CcSEcCtD
Carbimazole—Nervous system disorder—Irinotecan—lung cancer	0.000813	0.00163	CcSEcCtD
Carbimazole—Thrombocytopenia—Irinotecan—lung cancer	0.000812	0.00162	CcSEcCtD
Carbimazole—Haemoglobin—Docetaxel—lung cancer	0.000811	0.00162	CcSEcCtD
Carbimazole—Haemorrhage—Docetaxel—lung cancer	0.000807	0.00161	CcSEcCtD
Carbimazole—Hepatitis—Docetaxel—lung cancer	0.000807	0.00161	CcSEcCtD
Carbimazole—Infection—Gemcitabine—lung cancer	0.000803	0.0016	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—SMARCA4—lung cancer	0.000799	0.0041	CbGpPWpGaD
Carbimazole—Urticaria—Vinorelbine—lung cancer	0.000799	0.0016	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000799	0.0041	CbGpPWpGaD
Carbimazole—Body temperature increased—Vinorelbine—lung cancer	0.000795	0.00159	CcSEcCtD
Carbimazole—Nervous system disorder—Gemcitabine—lung cancer	0.000792	0.00158	CcSEcCtD
Carbimazole—Thrombocytopenia—Gemcitabine—lung cancer	0.000791	0.00158	CcSEcCtD
Carbimazole—TPO—Metabolism—CKB—lung cancer	0.000789	0.00405	CbGpPWpGaD
Carbimazole—Myalgia—Cisplatin—lung cancer	0.000786	0.00157	CcSEcCtD
Carbimazole—Skin disorder—Gemcitabine—lung cancer	0.000785	0.00157	CcSEcCtD
Carbimazole—Ill-defined disorder—Etoposide—lung cancer	0.000784	0.00157	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.00078	0.00156	CcSEcCtD
Carbimazole—Liver function test abnormal—Methotrexate—lung cancer	0.000776	0.00155	CcSEcCtD
Carbimazole—Discomfort—Cisplatin—lung cancer	0.000776	0.00155	CcSEcCtD
Carbimazole—Ill-defined disorder—Paclitaxel—lung cancer	0.000769	0.00154	CcSEcCtD
Carbimazole—Malaise—Etoposide—lung cancer	0.000762	0.00152	CcSEcCtD
Carbimazole—Headache—Vinblastine—lung cancer	0.000758	0.00151	CcSEcCtD
Carbimazole—Angioedema—Paclitaxel—lung cancer	0.000757	0.00151	CcSEcCtD
Carbimazole—Leukopenia—Etoposide—lung cancer	0.000757	0.00151	CcSEcCtD
Carbimazole—CYP19A1—Tryptophan metabolism—MDM2—lung cancer	0.000752	0.00386	CbGpPWpGaD
Carbimazole—Infection—Cisplatin—lung cancer	0.000748	0.0015	CcSEcCtD
Carbimazole—Malaise—Paclitaxel—lung cancer	0.000747	0.00149	CcSEcCtD
Carbimazole—Leukopenia—Paclitaxel—lung cancer	0.000742	0.00148	CcSEcCtD
Carbimazole—TPO—Metabolism—CNDP2—lung cancer	0.000742	0.00381	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTM2—lung cancer	0.000742	0.00381	CbGpPWpGaD
Carbimazole—Rash—Topotecan—lung cancer	0.000741	0.00148	CcSEcCtD
Carbimazole—Hypersensitivity—Vinorelbine—lung cancer	0.000741	0.00148	CcSEcCtD
Carbimazole—Dermatitis—Topotecan—lung cancer	0.000741	0.00148	CcSEcCtD
Carbimazole—Nervous system disorder—Cisplatin—lung cancer	0.000738	0.00148	CcSEcCtD
Carbimazole—Thrombocytopenia—Cisplatin—lung cancer	0.000737	0.00147	CcSEcCtD
Carbimazole—Headache—Topotecan—lung cancer	0.000736	0.00147	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000736	0.00147	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000735	0.00377	CbGpPWpGaD
Carbimazole—Rash—Erlotinib—lung cancer	0.000733	0.00147	CcSEcCtD
Carbimazole—Dermatitis—Erlotinib—lung cancer	0.000733	0.00146	CcSEcCtD
Carbimazole—Angiopathy—Docetaxel—lung cancer	0.000732	0.00146	CcSEcCtD
Carbimazole—Skin disorder—Cisplatin—lung cancer	0.000731	0.00146	CcSEcCtD
Carbimazole—Headache—Erlotinib—lung cancer	0.000729	0.00146	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—HPGDS—lung cancer	0.000724	0.00372	CbGpPWpGaD
Carbimazole—TPO—Metabolism—MTMR3—lung cancer	0.000722	0.0037	CbGpPWpGaD
Carbimazole—Eosinophilia—Methotrexate—lung cancer	0.000719	0.00144	CcSEcCtD
Carbimazole—Nausea—Vinblastine—lung cancer	0.000719	0.00144	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ANXA1—lung cancer	0.000717	0.00368	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000715	0.00143	CcSEcCtD
Carbimazole—Alopecia—Docetaxel—lung cancer	0.000713	0.00143	CcSEcCtD
Carbimazole—Pruritus—Vinorelbine—lung cancer	0.000711	0.00142	CcSEcCtD
Carbimazole—Discomfort—Etoposide—lung cancer	0.000711	0.00142	CcSEcCtD
Carbimazole—Arthralgia—Paclitaxel—lung cancer	0.000706	0.00141	CcSEcCtD
Carbimazole—Myalgia—Paclitaxel—lung cancer	0.000706	0.00141	CcSEcCtD
Carbimazole—TPO—Metabolism—PGAM1—lung cancer	0.000703	0.00361	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTT1—lung cancer	0.000703	0.00361	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000701	0.0014	CcSEcCtD
Carbimazole—Nausea—Topotecan—lung cancer	0.000698	0.0014	CcSEcCtD
Carbimazole—Discomfort—Paclitaxel—lung cancer	0.000697	0.00139	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP2A6—lung cancer	0.000695	0.00356	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GCLC—lung cancer	0.000695	0.00356	CbGpPWpGaD
Carbimazole—Nausea—Erlotinib—lung cancer	0.000691	0.00138	CcSEcCtD
Carbimazole—Pancytopenia—Methotrexate—lung cancer	0.00069	0.00138	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000686	0.00137	CcSEcCtD
Carbimazole—Infection—Etoposide—lung cancer	0.000685	0.00137	CcSEcCtD
Carbimazole—Feeling abnormal—Irinotecan—lung cancer	0.000683	0.00137	CcSEcCtD
Carbimazole—Neutropenia—Methotrexate—lung cancer	0.000679	0.00136	CcSEcCtD
Carbimazole—Thrombocytopenia—Etoposide—lung cancer	0.000675	0.00135	CcSEcCtD
Carbimazole—Liver function test abnormal—Doxorubicin—lung cancer	0.000672	0.00134	CcSEcCtD
Carbimazole—Infection—Paclitaxel—lung cancer	0.000672	0.00134	CcSEcCtD
Carbimazole—TPO—Metabolism—CYP2A7—lung cancer	0.000671	0.00344	CbGpPWpGaD
Carbimazole—Skin disorder—Etoposide—lung cancer	0.00067	0.00134	CcSEcCtD
Carbimazole—Feeling abnormal—Gemcitabine—lung cancer	0.000666	0.00133	CcSEcCtD
Carbimazole—Nervous system disorder—Paclitaxel—lung cancer	0.000663	0.00133	CcSEcCtD
Carbimazole—Thrombocytopenia—Paclitaxel—lung cancer	0.000662	0.00132	CcSEcCtD
Carbimazole—Skin disorder—Paclitaxel—lung cancer	0.000657	0.00131	CcSEcCtD
Carbimazole—TPO—Metabolism—SDC4—lung cancer	0.000657	0.00337	CbGpPWpGaD
Carbimazole—Body temperature increased—Irinotecan—lung cancer	0.000656	0.00131	CcSEcCtD
Carbimazole—Body temperature increased—Gemcitabine—lung cancer	0.000639	0.00128	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000635	0.00326	CbGpPWpGaD
Carbimazole—Rash—Vinorelbine—lung cancer	0.000634	0.00127	CcSEcCtD
Carbimazole—Dermatitis—Vinorelbine—lung cancer	0.000633	0.00127	CcSEcCtD
Carbimazole—Stomatitis—Methotrexate—lung cancer	0.000632	0.00126	CcSEcCtD
Carbimazole—Headache—Vinorelbine—lung cancer	0.00063	0.00126	CcSEcCtD
Carbimazole—Leukopenia—Docetaxel—lung cancer	0.000629	0.00126	CcSEcCtD
Carbimazole—Eosinophilia—Doxorubicin—lung cancer	0.000623	0.00124	CcSEcCtD
Carbimazole—Feeling abnormal—Cisplatin—lung cancer	0.000621	0.00124	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000616	0.00123	CcSEcCtD
Carbimazole—Hypersensitivity—Irinotecan—lung cancer	0.000611	0.00122	CcSEcCtD
Carbimazole—Agranulocytosis—Methotrexate—lung cancer	0.000605	0.00121	CcSEcCtD
Carbimazole—Myalgia—Docetaxel—lung cancer	0.000598	0.0012	CcSEcCtD
Carbimazole—Arthralgia—Docetaxel—lung cancer	0.000598	0.0012	CcSEcCtD
Carbimazole—TPO—Metabolism—RRM1—lung cancer	0.000598	0.00307	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTA3—lung cancer	0.000598	0.00307	CbGpPWpGaD
Carbimazole—Pancytopenia—Doxorubicin—lung cancer	0.000598	0.00119	CcSEcCtD
Carbimazole—Nausea—Vinorelbine—lung cancer	0.000597	0.00119	CcSEcCtD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000596	0.00306	CbGpPWpGaD
Carbimazole—Body temperature increased—Cisplatin—lung cancer	0.000595	0.00119	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000594	0.00119	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP2E1—lung cancer	0.000591	0.00303	CbGpPWpGaD
Carbimazole—Neutropenia—Doxorubicin—lung cancer	0.000588	0.00118	CcSEcCtD
Carbimazole—Haemoglobin—Methotrexate—lung cancer	0.000585	0.00117	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—STK11—lung cancer	0.000584	0.003	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP2E1—lung cancer	0.000582	0.00299	CbGpPWpGaD
Carbimazole—Hepatitis—Methotrexate—lung cancer	0.000582	0.00116	CcSEcCtD
Carbimazole—Haemorrhage—Methotrexate—lung cancer	0.000582	0.00116	CcSEcCtD
Carbimazole—Pruritus—Gemcitabine—lung cancer	0.000572	0.00114	CcSEcCtD
Carbimazole—Infection—Docetaxel—lung cancer	0.00057	0.00114	CcSEcCtD
Carbimazole—Feeling abnormal—Etoposide—lung cancer	0.000568	0.00114	CcSEcCtD
Carbimazole—Nervous system disorder—Docetaxel—lung cancer	0.000562	0.00112	CcSEcCtD
Carbimazole—TPO—Metabolism—B4GALT5—lung cancer	0.000562	0.00289	CbGpPWpGaD
Carbimazole—Thrombocytopenia—Docetaxel—lung cancer	0.000561	0.00112	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—lung cancer	0.000558	0.00286	CbGpPWpGaD
Carbimazole—Feeling abnormal—Paclitaxel—lung cancer	0.000557	0.00111	CcSEcCtD
Carbimazole—Skin disorder—Docetaxel—lung cancer	0.000557	0.00111	CcSEcCtD
Carbimazole—Hypersensitivity—Cisplatin—lung cancer	0.000555	0.00111	CcSEcCtD
Carbimazole—Urticaria—Etoposide—lung cancer	0.000548	0.0011	CcSEcCtD
Carbimazole—TPO—Metabolism—GSTA4—lung cancer	0.000547	0.00281	CbGpPWpGaD
Carbimazole—Stomatitis—Doxorubicin—lung cancer	0.000547	0.00109	CcSEcCtD
Carbimazole—Jaundice—Doxorubicin—lung cancer	0.000547	0.00109	CcSEcCtD
Carbimazole—Body temperature increased—Etoposide—lung cancer	0.000545	0.00109	CcSEcCtD
Carbimazole—Urticaria—Paclitaxel—lung cancer	0.000537	0.00107	CcSEcCtD
Carbimazole—Body temperature increased—Paclitaxel—lung cancer	0.000535	0.00107	CcSEcCtD
Carbimazole—TPO—Metabolism—GSTA2—lung cancer	0.000533	0.00274	CbGpPWpGaD
Carbimazole—Angiopathy—Methotrexate—lung cancer	0.000528	0.00105	CcSEcCtD
Carbimazole—Agranulocytosis—Doxorubicin—lung cancer	0.000524	0.00105	CcSEcCtD
Carbimazole—Rash—Irinotecan—lung cancer	0.000523	0.00105	CcSEcCtD
Carbimazole—Dermatitis—Irinotecan—lung cancer	0.000522	0.00104	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000522	0.00104	CcSEcCtD
Carbimazole—Headache—Irinotecan—lung cancer	0.00052	0.00104	CcSEcCtD
Carbimazole—TPO—Metabolism—GSTA1—lung cancer	0.000514	0.00264	CbGpPWpGaD
Carbimazole—Alopecia—Methotrexate—lung cancer	0.000514	0.00103	CcSEcCtD
Carbimazole—Rash—Gemcitabine—lung cancer	0.000509	0.00102	CcSEcCtD
Carbimazole—Dermatitis—Gemcitabine—lung cancer	0.000509	0.00102	CcSEcCtD
Carbimazole—TPO—Metabolism—ABCC3—lung cancer	0.000508	0.00261	CbGpPWpGaD
Carbimazole—Hypersensitivity—Etoposide—lung cancer	0.000508	0.00102	CcSEcCtD
Carbimazole—Haemoglobin—Doxorubicin—lung cancer	0.000506	0.00101	CcSEcCtD
Carbimazole—Headache—Gemcitabine—lung cancer	0.000506	0.00101	CcSEcCtD
Carbimazole—Haemorrhage—Doxorubicin—lung cancer	0.000504	0.00101	CcSEcCtD
Carbimazole—Hepatitis—Doxorubicin—lung cancer	0.000504	0.00101	CcSEcCtD
Carbimazole—Hypersensitivity—Paclitaxel—lung cancer	0.000498	0.000996	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	0.000494	0.00253	CbGpPWpGaD
Carbimazole—Nausea—Irinotecan—lung cancer	0.000493	0.000985	CcSEcCtD
Carbimazole—TPO—Metabolism—AKR1C1—lung cancer	0.000492	0.00253	CbGpPWpGaD
Carbimazole—Pruritus—Etoposide—lung cancer	0.000488	0.000975	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTP1—lung cancer	0.000487	0.0025	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTP1—lung cancer	0.00048	0.00247	CbGpPWpGaD
Carbimazole—Nausea—Gemcitabine—lung cancer	0.00048	0.000959	CcSEcCtD
Carbimazole—Pruritus—Paclitaxel—lung cancer	0.000479	0.000956	CcSEcCtD
Carbimazole—TPO—Metabolism—UGT1A1—lung cancer	0.000478	0.00245	CbGpPWpGaD
Carbimazole—Rash—Cisplatin—lung cancer	0.000475	0.000949	CcSEcCtD
Carbimazole—Dermatitis—Cisplatin—lung cancer	0.000474	0.000948	CcSEcCtD
Carbimazole—Feeling abnormal—Docetaxel—lung cancer	0.000472	0.000944	CcSEcCtD
Carbimazole—Ill-defined disorder—Methotrexate—lung cancer	0.00047	0.000939	CcSEcCtD
Carbimazole—TPO—Metabolism—GNG11—lung cancer	0.000461	0.00237	CbGpPWpGaD
Carbimazole—Angiopathy—Doxorubicin—lung cancer	0.000457	0.000913	CcSEcCtD
Carbimazole—Malaise—Methotrexate—lung cancer	0.000457	0.000912	CcSEcCtD
Carbimazole—Body temperature increased—Docetaxel—lung cancer	0.000453	0.000906	CcSEcCtD
Carbimazole—Leukopenia—Methotrexate—lung cancer	0.000453	0.000906	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—GSTM1—lung cancer	0.000448	0.0023	CbGpPWpGaD
Carbimazole—Nausea—Cisplatin—lung cancer	0.000447	0.000894	CcSEcCtD
Carbimazole—Alopecia—Doxorubicin—lung cancer	0.000445	0.000889	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTM1—lung cancer	0.000441	0.00227	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALDOA—lung cancer	0.000439	0.00225	CbGpPWpGaD
Carbimazole—Rash—Etoposide—lung cancer	0.000435	0.000869	CcSEcCtD
Carbimazole—Dermatitis—Etoposide—lung cancer	0.000435	0.000868	CcSEcCtD
Carbimazole—Headache—Etoposide—lung cancer	0.000432	0.000864	CcSEcCtD
Carbimazole—Arthralgia—Methotrexate—lung cancer	0.000431	0.000861	CcSEcCtD
Carbimazole—Myalgia—Methotrexate—lung cancer	0.000431	0.000861	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000428	0.000855	CcSEcCtD
Carbimazole—Rash—Paclitaxel—lung cancer	0.000426	0.000852	CcSEcCtD
Carbimazole—Dermatitis—Paclitaxel—lung cancer	0.000426	0.000852	CcSEcCtD
Carbimazole—TPO—Metabolism—NCOA3—lung cancer	0.000426	0.00219	CbGpPWpGaD
Carbimazole—Discomfort—Methotrexate—lung cancer	0.000426	0.000851	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—CYP1A1—lung cancer	0.000424	0.00218	CbGpPWpGaD
Carbimazole—Headache—Paclitaxel—lung cancer	0.000424	0.000847	CcSEcCtD
Carbimazole—Hypersensitivity—Docetaxel—lung cancer	0.000422	0.000844	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MMP1—lung cancer	0.000422	0.00217	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—CYP1A1—lung cancer	0.000418	0.00215	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCG2—lung cancer	0.000414	0.00213	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ADCY1—lung cancer	0.000414	0.00213	CbGpPWpGaD
Carbimazole—Infection—Methotrexate—lung cancer	0.000411	0.00082	CcSEcCtD
Carbimazole—Nausea—Etoposide—lung cancer	0.00041	0.000819	CcSEcCtD
Carbimazole—Ill-defined disorder—Doxorubicin—lung cancer	0.000407	0.000813	CcSEcCtD
Carbimazole—TPO—Metabolism—HPGDS—lung cancer	0.000406	0.00209	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ENO2—lung cancer	0.000406	0.00209	CbGpPWpGaD
Carbimazole—Pruritus—Docetaxel—lung cancer	0.000406	0.000811	CcSEcCtD
Carbimazole—Nervous system disorder—Methotrexate—lung cancer	0.000405	0.00081	CcSEcCtD
Carbimazole—Thrombocytopenia—Methotrexate—lung cancer	0.000405	0.000809	CcSEcCtD
Carbimazole—TPO—Metabolism—PPP2R1B—lung cancer	0.000404	0.00207	CbGpPWpGaD
Carbimazole—Nausea—Paclitaxel—lung cancer	0.000402	0.000803	CcSEcCtD
Carbimazole—Skin disorder—Methotrexate—lung cancer	0.000401	0.000802	CcSEcCtD
Carbimazole—Malaise—Doxorubicin—lung cancer	0.000395	0.00079	CcSEcCtD
Carbimazole—TPO—Metabolism—GSTT1—lung cancer	0.000394	0.00202	CbGpPWpGaD
Carbimazole—Leukopenia—Doxorubicin—lung cancer	0.000392	0.000784	CcSEcCtD
Carbimazole—TPO—Metabolism—GCLC—lung cancer	0.00039	0.002	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP2A6—lung cancer	0.00039	0.002	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000376	0.000752	CcSEcCtD
Carbimazole—Arthralgia—Doxorubicin—lung cancer	0.000373	0.000746	CcSEcCtD
Carbimazole—Myalgia—Doxorubicin—lung cancer	0.000373	0.000746	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—AZIN2—lung cancer	0.000373	0.00192	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—COL4A3BP—lung cancer	0.000373	0.00192	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000371	0.000741	CcSEcCtD
Carbimazole—TPO—Metabolism—ENO1—lung cancer	0.000369	0.0019	CbGpPWpGaD
Carbimazole—Discomfort—Doxorubicin—lung cancer	0.000369	0.000737	CcSEcCtD
Carbimazole—Rash—Docetaxel—lung cancer	0.000361	0.000722	CcSEcCtD
Carbimazole—Dermatitis—Docetaxel—lung cancer	0.000361	0.000722	CcSEcCtD
Carbimazole—Headache—Docetaxel—lung cancer	0.000359	0.000718	CcSEcCtD
Carbimazole—Infection—Doxorubicin—lung cancer	0.000355	0.00071	CcSEcCtD
Carbimazole—Nervous system disorder—Doxorubicin—lung cancer	0.000351	0.000701	CcSEcCtD
Carbimazole—Thrombocytopenia—Doxorubicin—lung cancer	0.00035	0.0007	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	0.000348	0.00179	CbGpPWpGaD
Carbimazole—Skin disorder—Doxorubicin—lung cancer	0.000348	0.000695	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—lung cancer	0.000347	0.00178	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP8—lung cancer	0.000343	0.00176	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—RB1—lung cancer	0.000341	0.00175	CbGpPWpGaD
Carbimazole—Nausea—Docetaxel—lung cancer	0.000341	0.000681	CcSEcCtD
Carbimazole—Feeling abnormal—Methotrexate—lung cancer	0.000341	0.000681	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CDH1—lung cancer	0.000339	0.00174	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	0.000337	0.00173	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP2E1—lung cancer	0.000331	0.0017	CbGpPWpGaD
Carbimazole—Urticaria—Methotrexate—lung cancer	0.000328	0.000656	CcSEcCtD
Carbimazole—TPO—Metabolism—NQO1—lung cancer	0.000328	0.00168	CbGpPWpGaD
Carbimazole—Body temperature increased—Methotrexate—lung cancer	0.000327	0.000653	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000326	0.000651	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—ATP5H—lung cancer	0.000317	0.00163	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—POMC—lung cancer	0.000316	0.00162	CbGpPWpGaD
Carbimazole—Hypersensitivity—Methotrexate—lung cancer	0.000304	0.000608	CcSEcCtD
Carbimazole—TPO—Metabolism—STK11—lung cancer	0.000295	0.00152	CbGpPWpGaD
Carbimazole—Feeling abnormal—Doxorubicin—lung cancer	0.000295	0.000589	CcSEcCtD
Carbimazole—Pruritus—Methotrexate—lung cancer	0.000292	0.000584	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	0.000292	0.0015	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MDM2—lung cancer	0.00029	0.00149	CbGpPWpGaD
Carbimazole—Urticaria—Doxorubicin—lung cancer	0.000284	0.000568	CcSEcCtD
Carbimazole—Body temperature increased—Doxorubicin—lung cancer	0.000283	0.000565	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—PLBD1—lung cancer	0.000283	0.00145	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MTOR—lung cancer	0.000283	0.00145	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	0.000278	0.00143	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTP1—lung cancer	0.000273	0.0014	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CAT—lung cancer	0.000266	0.00136	CbGpPWpGaD
Carbimazole—Hypersensitivity—Doxorubicin—lung cancer	0.000264	0.000527	CcSEcCtD
Carbimazole—Rash—Methotrexate—lung cancer	0.000261	0.000521	CcSEcCtD
Carbimazole—Dermatitis—Methotrexate—lung cancer	0.00026	0.00052	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—lung cancer	0.00026	0.00133	CbGpPWpGaD
Carbimazole—Headache—Methotrexate—lung cancer	0.000259	0.000517	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—HSD17B10—lung cancer	0.000259	0.00133	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ABCB1—lung cancer	0.000259	0.00133	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TYMS—lung cancer	0.000254	0.0013	CbGpPWpGaD
Carbimazole—Pruritus—Doxorubicin—lung cancer	0.000253	0.000506	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—lung cancer	0.000253	0.0013	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—JUN—lung cancer	0.000252	0.0013	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTM1—lung cancer	0.000251	0.00129	CbGpPWpGaD
Carbimazole—Nausea—Methotrexate—lung cancer	0.000245	0.000491	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—lung cancer	0.000244	0.00125	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CKB—lung cancer	0.00024	0.00123	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CYP1A1—lung cancer	0.000238	0.00122	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ERCC2—lung cancer	0.000236	0.00121	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EP300—lung cancer	0.000233	0.0012	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM2—lung cancer	0.000226	0.00116	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CNDP2—lung cancer	0.000226	0.00116	CbGpPWpGaD
Carbimazole—Rash—Doxorubicin—lung cancer	0.000226	0.000451	CcSEcCtD
Carbimazole—Dermatitis—Doxorubicin—lung cancer	0.000225	0.00045	CcSEcCtD
Carbimazole—Headache—Doxorubicin—lung cancer	0.000224	0.000448	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—lung cancer	0.000221	0.00113	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—MTMR3—lung cancer	0.00022	0.00113	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PGAM1—lung cancer	0.000214	0.0011	CbGpPWpGaD
Carbimazole—Nausea—Doxorubicin—lung cancer	0.000213	0.000425	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—CYP2A7—lung cancer	0.000204	0.00105	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOA1—lung cancer	0.000204	0.00105	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—MYC—lung cancer	0.000203	0.00104	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SDC4—lung cancer	0.0002	0.00103	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—EGFR—lung cancer	0.000198	0.00102	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—lung cancer	0.000188	0.000962	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CG—lung cancer	0.000186	0.000957	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—RRM1—lung cancer	0.000182	0.000935	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA3—lung cancer	0.000182	0.000935	CbGpPWpGaD
Carbimazole—TPO—Metabolism—POMC—lung cancer	0.000177	0.000911	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CREBBP—lung cancer	0.000173	0.000887	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—B4GALT5—lung cancer	0.000171	0.000879	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA4—lung cancer	0.000167	0.000855	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—lung cancer	0.000167	0.000855	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CD—lung cancer	0.000164	0.000841	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	0.000163	0.000836	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA2—lung cancer	0.000162	0.000834	CbGpPWpGaD
Carbimazole—TPO—Metabolism—ALB—lung cancer	0.000162	0.000831	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTA1—lung cancer	0.000157	0.000804	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCC3—lung cancer	0.000155	0.000795	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKR1C1—lung cancer	0.00015	0.00077	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—UGT1A1—lung cancer	0.000146	0.000748	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CB—lung cancer	0.000143	0.000733	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—lung cancer	0.000142	0.000727	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—lung cancer	0.000141	0.000722	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GNG11—lung cancer	0.00014	0.000721	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	0.00014	0.000717	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALDOA—lung cancer	0.000134	0.000687	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NCOA3—lung cancer	0.00013	0.000666	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	0.000128	0.000655	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ADCY1—lung cancer	0.000126	0.000648	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCG2—lung cancer	0.000126	0.000648	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HPGDS—lung cancer	0.000124	0.000636	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ENO2—lung cancer	0.000124	0.000636	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTEN—lung cancer	0.000123	0.000634	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPP2R1B—lung cancer	0.000123	0.000632	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—POMC—lung cancer	0.000121	0.000623	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTT1—lung cancer	0.00012	0.000617	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GCLC—lung cancer	0.000119	0.00061	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2A6—lung cancer	0.000119	0.00061	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	0.000118	0.000607	CbGpPWpGaD
Carbimazole—TPO—Metabolism—EP300—lung cancer	0.000118	0.000604	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ENO1—lung cancer	0.000113	0.000578	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	0.000112	0.000576	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—lung cancer	0.000111	0.000568	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP2E1—lung cancer	0.000101	0.000518	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—NQO1—lung cancer	9.99e-05	0.000512	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.78e-05	0.000502	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.69e-05	0.000497	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—STK11—lung cancer	9e-05	0.000462	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PIK3CA—lung cancer	8.71e-05	0.000447	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.45e-05	0.000434	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTP1—lung cancer	8.33e-05	0.000427	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CAT—lung cancer	8.1e-05	0.000416	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.06e-05	0.000414	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ABCB1—lung cancer	7.88e-05	0.000405	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TYMS—lung cancer	7.74e-05	0.000397	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTM1—lung cancer	7.65e-05	0.000393	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CYP1A1—lung cancer	7.26e-05	0.000372	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ERCC2—lung cancer	7.2e-05	0.000369	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—lung cancer	7.12e-05	0.000365	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOA1—lung cancer	6.22e-05	0.000319	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.96e-05	0.000306	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CG—lung cancer	5.68e-05	0.000292	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—POMC—lung cancer	5.41e-05	0.000278	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CREBBP—lung cancer	5.27e-05	0.00027	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CD—lung cancer	5e-05	0.000256	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—ALB—lung cancer	4.93e-05	0.000253	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CB—lung cancer	4.35e-05	0.000223	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—lung cancer	4.31e-05	0.000221	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTEN—lung cancer	3.76e-05	0.000193	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—EP300—lung cancer	3.59e-05	0.000184	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PIK3CA—lung cancer	2.65e-05	0.000136	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—lung cancer	2.17e-05	0.000111	CbGpPWpGaD
